£5 million invested in global ME research over 25 years

GLP-1 receptor agonists for ME/CFS?

GLP-1 receptor agonists are currently licensed for the treatment of type 2 diabetes and for weight management in overweight/obese individuals.…
Verified by MonsterInsights